White Pine Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$448K Buy
894
+203
+29% +$97.5K 0.11% 181
2026
Q1
$340K Buy
691
+8
+1% +$4.34K 0.09% 193
2025
Q4
$396K Buy
683
+72
+12% +$40.7K 0.11% 176
2025
Q3
$296K Buy
611
+19
+3% +$8.84K 0.08% 203
2025
Q2
$240K Sell
592
-10
-2% -$4.18K 0.08% 212
2025
Q1
$300K Buy
602
+80
+15% +$43.3K 0.1% 186
2024
Q4
$272K Buy
522
+1
+0.2% +$550 0.09% 197
2024
Q3
$322K Buy
521
+7
+1% +$4.14K 0.11% 184
2024
Q2
$284K Buy
514
+11
+2% +$6.3K 0.11% 185
2024
Q1
$286K Buy
503
+30
+6% +$16.8K 0.11% 180
2023
Q4
$251K Buy
473
+10
+2% +$4.84K 0.1% 191
2023
Q3
$234K Buy
+463
New +$247K 0.09% 190

Other funds holding TMO

White Pine Capital's TMO Position: Q2 2026 in Review

White Pine Capital increased its Thermo Fisher Scientific (TMO) stake by 29% in Q2 2026, buying an estimated $97.5K and bringing the position to 894 shares worth $448K. The position accounts for 0.11% of the portfolio, ranked #181.

White Pine Capital first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • White Pine Capital held 894 shares of Thermo Fisher Scientific worth $448K as of Q2 2026.
  • White Pine Capital bought 203 Thermo Fisher Scientific shares in Q2 2026, an estimated $97.5K.
  • Thermo Fisher Scientific made up 0.11% of White Pine Capital's portfolio in Q2 2026, its #181 holding.
  • White Pine Capital first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on White Pine Capital's 13F filing for Q2 2026, filed 5 Aug 2026.